Shopping Cart
Remove All
Your shopping cart is currently empty
GNE-140 is a novel and potent lactate dehydrogenase A (LDHA) inhibitor that disrupts glycolytic metabolism in MIA PaCa-2 human pancreatic cancer cells, inducing rapid metabolic reprogramming prior to delayed cell death, with intrinsic resistance observed in OXPHOS-dependent pancreatic cell lines that can be reversed by phenformin, while acquired resistance is driven by AMPK-mTOR-S6K pathway activation, highlighting its value for studying metabolic plasticity and therapeutic resistance.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $333 | - | In Stock | |
| 5 mg | $790 | - | In Stock | |
| 10 mg | $1,120 | - | In Stock | |
| 25 mg | $1,670 | - | In Stock | |
| 50 mg | $2,180 | - | In Stock | |
| 100 mg | $2,800 | - | In Stock |
| Description | GNE-140 is a novel and potent lactate dehydrogenase A (LDHA) inhibitor that disrupts glycolytic metabolism in MIA PaCa-2 human pancreatic cancer cells, inducing rapid metabolic reprogramming prior to delayed cell death, with intrinsic resistance observed in OXPHOS-dependent pancreatic cell lines that can be reversed by phenformin, while acquired resistance is driven by AMPK-mTOR-S6K pathway activation, highlighting its value for studying metabolic plasticity and therapeutic resistance. |
| Targets&IC50 | LDHA:3 nM |
| Synonyms | GNE140, GNE 140 |
| Molecular Weight | 499.04 |
| Formula | C25H23ClN2O3S2 |
| Cas No. | 1809794-70-4 |
| Smiles | O=C1NC(C2=CSC=C2)(C3=CC=C(C=C3)N4CCOCC4)CC(O)=C1SC=5C=CC=CC5Cl |
| Relative Density. | 1.46 g/cm3 (Predicted) |
| Color | Brown |
| Appearance | Solid |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.